期刊文献+

脓毒症休克患者抗感染治疗策略及用药分析 被引量:9

Antimicrobial Therapy and Case Analysis in Patients with Sepsis Shock
下载PDF
导出
摘要 脓毒症休克的抗感染治疗策略包括控制感染源、早期有效的抗菌药物治疗、降阶梯治疗、目标性治疗及根据抗菌药物药代动力学、药效学特点优化抗菌药物给药方案。临床药师在重症患者治疗过程中应发挥专业特长。本文结合1例脓毒症休克合并急性肾功能不全患者的美罗培南给药方案的调整为例,佐证药师建议采用缩短给药间隔以及两步滴定法给药,使治疗取得良好效果,患者病情明显好转出院。 Antimicrobial therapy in patients with sepsis shock include infection source control, early and effective anti-infection therapy, de-escalation therapy, targeted therapy and optimizing dosing regimen of antibiotics based on the principle of PK/PD. Clinical pharmacists should help doctors formulate individual dosage regimens for severe patients with their specialized knowledge. Pharmacists assisted physicians to adjust the meropenem regimens for a patient with sepsis shock complicating with acute renal insufficiency through two-step infusion therapy and shorter dosing interval. Clinical physicians adopted the advice provided by pharmacists, and the patient experienced the treatment process smoothly and was improved greatly to leave hospital.
作者 张秀红 钱俊
出处 《药学与临床研究》 2015年第2期188-190,共3页 Pharmaceutical and Clinical Research
基金 无锡市医院管理中心2013年药学基金资助项目(YGZXY1308)
关键词 脓毒症休克 抗感染治疗 案例分析 临床药师 Sepsis shock Antimicrobial therapy Case analysis Clinical pharmacist
  • 相关文献

参考文献1

二级参考文献22

  • 1孟新科,杨径,吴华雄,朱虹,郑晓英,魏刚,刘德红,苏顺庭.MEWS与APACHEⅡ评分在急诊潜在危重病患者病情评价和预后预测中的对比研究[J].实用临床医药杂志,2005,9(8):1-4. 被引量:158
  • 2张维,张杰.碳青霉烯类抗生素的药动学和药效学研究进展[J].中国实用内科杂志,2007,27(5):386-389. 被引量:14
  • 3王广基.药物代谢动力学[M].北京:化学工业出版社,2006:97-102.
  • 4Jacobs M. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters[ J]. Clin Microbiol Infect, 2001, 7 ( 11 ) : 589-596.
  • 5Turnidge JD. The pharmacodynamics of β-lactams [ J ]. Clin Infect Dis, 1998, 27(1) : 10-22.
  • 6Eguchi K, Kanazawa K, Shimizudani T, et al. Experimental verification of the efficacy of optimized two-step infusion therapy with meropenem using an in vitro pharmacodynamic model and Monte Carlo simulation[ J]. J Infect Chemother, 2010. 16(1) : 1-9.
  • 7McDonald PJ, Craig WA, Kunin CM. Persistent effect of antibiotics on Staphylococcus arueus after exposure for limited periods of time [J]. J Infect Dis, 1977,135(2) : 217-223.
  • 8Elkhaili H, Niedergang S, Pompei D, et al. High-performance liquid chromatographic assay for mempenem in serum[ J]. J Chromatogr B Biomed Appl, 1996,686 ( 1 ) : 19-26.
  • 9pharsight C. WinNonlin Examples Guide. Available from : http ://www. pharsight, com. support@ pharsight, com.
  • 10Eagle H, Fleischman R, Levy, M. Continuous vs. discontinuous therapy with penicillin[ J]. N Engl J Med, 1953,248 (12) :481- 488.

共引文献3

同被引文献84

  • 1肖红丽,曹邦伟,荷欢,阴赪宏.美罗培南与亚胺培南治疗中、重度肺部感染疗效与安全性的荟萃分析[J].中国感染与化疗杂志,2010,10(4):264-269. 被引量:40
  • 2抗菌药物临床应用指导原则[J].中国临床药学杂志,2005,14(3). 被引量:82
  • 3王勇,秦开秀.乌司他丁对急性肺损伤小鼠肺组织中白细胞介素-10表达的影响[J].中国药业,2007,16(9):10-11. 被引量:5
  • 4陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2010:2044.
  • 5Dandekar P K, Maglio D, Sutherland C A, et al. Pharmacokineties of mero- penem 0. 5 and 2g every 8 hours as a 3-hour infusion [ J ]. Pharmacotherapy, 2003,23 (8) :988-991.
  • 6Jaruratanasirikul S, Sriwiriyajan S, Punyo J. Comparison of the pharmacody- namics of meropenem in pnjection[ J ]. Antimicrob Agents Chemother,2005, 49(4) :1337-1339.
  • 7Davies Forsman L,Giske C G,Bruchfeld J,et al.Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis[J].Antimicrobial agents and chemotherapy,2015,59(6):3630.
  • 8Kumar A,Zarychanski R,Light B,et al.Early combination antibiotic therapy yields improved survival compared to monotherapy in septic shock:a propensity-matchedanalysis[J].Crit Care Med,2010,38(9):1773.
  • 9Dellinger RP,Levy MM,Rhodes A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Inten-sive Care Med,2013,39(2):165.
  • 10Vourli S,Frantzeskaki F,Meletiadis J,et al.Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients[J].International journal of antimicrobial agent,2015,45(6):670.

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部